Sernova Corp T.SVA

Alternate Symbol(s): SEOVF

Healthcare Biotechnology

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.

TSX:SVA - Post by User

Sernova Corp > Insiders

<< Previous

Bullboard Posts

Next >>

Comment by Mercuryfilling1on Jan 19, 2022 4:01pm

181 Views

Post# 34334564

RE:RE:RE:Insiders

Ekenbullets:
Looking at the SEDI filings may make the numbers seem unimpressive but that's because you're viewing it piecemeal. Actual holdings of common shares, DSUs, and Options tell a different story. From INK Insider (as of December 16, 2021) these are Philip Toleikis's holdings. Incredibly bulgy around the waistline on the option side of things but he's been a net zero seller of common shares.

This chart reflects CEO holdings data displayed below over time.

This chart reflects CFO holdings data displayed below over tToleikis, Philip Michael

Relationship as filed with regulators: 4, 5 Latest filing date: December 16, 2021

Direct Ownership

Common Shares 4,803,425
Options 12,956,419
Warrants 45,002

Indirect Ownership

Common Shares 425,171 Options 0 Warrants 0

You can look up the other director's holdings on any number of platforms though you may have to pay. TD gives me INK free of charge. Your trading platform should have a research section, if not I'd switch to one that does.

<< Previous

Bullboard Posts

Next >>

Advancing flagship Ishkõday Gold Project in Ontario